Highbridge Capital Management LLC Bristol Myers Squibb CO Transaction History

Highbridge Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $1.5 Million - $1.94 Million	-30,734 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $2.78 Million - $3.13 Million	-50,347 Reduced 62.09%	30,734 $1.91 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $10.4 Million - $11.9 Million	-173,060 Reduced 68.1%	81,081 $5.13 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $8.11 Million - $8.84 Million	135,244 Added 113.75%	254,141 $15.6 Million
Q3 2017 Nov 14, 2017	SELL	$55.23 - $63.74 $5.93 Million - $6.84 Million	-107,286 Reduced 47.43%	118,897 $7.58 Million
Q2 2017 Aug 14, 2017	BUY	N/A	226,183	226,183 $12.6 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highbridge Capital Management LLC with notifications on news.